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Abstract
Background: Analysis of DNA microarray data usually begins with a normalization step where
intensities of different arrays are adjusted to the same scale so that the intensity levels from
different arrays can be compared with one other. Both simple total array intensity-based as well as
more complex "local intensity level" dependent normalization methods have been developed, some
of which are widely used. Much less developed methods for microarray data analysis include those
that bypass the normalization step and therefore yield results that are not confounded by potential
normalization errors.
Results:  Instead of focusing on the raw intensity levels, we developed a new method for
microarray data analysis that maps each gene's expression intensity level to a high dimensional
space of SEDs (Signs of Expression Difference), the signs of the expression intensity difference
between a given gene and every other gene on the array. Since SED are unchanged under any
monotonic transformation of intensity levels, the SED based method is normalization free. When
tested on a multi-class tumor classification problem, simple Naive Bayes and Nearest Neighbor
methods using the SED approach gave results comparable with normalized intensity-based
algorithms. Furthermore, a high percentage of classifiers based on a single gene's SED gave good
classification results, suggesting that SED does capture essential information from the intensity
levels.
Conclusion: The results of testing this new method on multi-class tumor classification problems
suggests that the SED-based, normalization-free method of microarray data analysis is feasible and
promising.
Background
DNA microarray technology is now playing an increas-
ingly important role in biomedical research. Microarray
technology gives one the opportunity to measure gene
expression levels of thousands to tens of thousands of
genes simultaneously, in order to study the differential
gene expression pattern between different developmental
stages, diseases states and samples treated with drugs or
other compounds. Before comparing data from different
arrays to address these biological questions, however, a
"much more mundane but indispensable " normalization
step [1] is currently used in most microarray analyses.
Because of the slight difference in RNA quantities, imag-
ing settings and other variables, even in very controlled
experiments the intensity levels from different arrays are
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of different scales and need to be normalized before they
can be compared with each other. Various normalization
methods have been developed and some are widely used.
The simplest method is total intensity based normaliza-
tion [2]; this approach scales intensity levels of every gene
by a constant factor so that total intensities of all the arrays
are the same. "Spiked-in" based normalization methods
scale intensity based on spiked-in standards [3]. Nonlin-
ear normalization methods use local regression to scale
intensities to compensate for the intensity-dependent dif-
ferences between arrays [4-6].
For most current applications, these normalization meth-
ods seem to be adequate. However, the residual left by a
less than perfect normalization procedure is another
source of non-biological variation that is usually non-
desirable, especially when the differences in expression
levels are expected to be small [7]. In addition, if the goal
is meta-analysis of multiple sets of microarray data [8,9]
systematic differences between experiments may result in
a normalization artifact. We were therefore interested in
developing an approach to analyse microarray data with-
out first performing a normalization step. Our approach
was partly inspired by non-parametric statistical methods
[10]. For example, nonparametric methods that use ranks
[11,12] to compare microarray results, in addition to
being distribution free, have the additional advantage of
being normalization free.
DNA microarray technology has been used widely in bio-
medical studies. One interesting application is in the area
of molecular classification; one popular use is in the com-
parison of tumor samples. Since clinical and histopatho-
logical classification is sometimes difficult and labor-
intensive, the use of genome wide expression patterns to
classify tumor samples has recently become a very active
research area [13-16]. Although some tumors appear to be
amenable to classification using microarray data [17,18],
general multiple tumor classification using microarray
data has proved to be an interesting and challenging task
for several reasons: the general difficulties inherent in
multi-class classification problems, the small number of
samples available, and the inherent biological variation
between specimens, etc. We decided to use multi-class
tumor classification as a test case to illustrate the power of
our approach. We compared our results for a multi-class
tumor classification problem with more conventional
approaches published by Ramaswamy et al. [19] and
Yeang CH et al. [20]. These authors compared the accura-
cies of using k-Nearest Neighbors (kNN, 60–70%),
Weighted Voting (WV, 60–70%) and Support Vector
Machine (SVM, 80%) algorithms in a multi-class tumor
classification problem and concluded that SVM is a more
powerful machine learning algorithm for this application.
Results
Normalization Free approach to microarray data analysis
Generally, measurements on single microarrays give a
real-valued intensity level xi (1<= i <= N) for each gene i
on the array, where N is the total number of genes on the
array. Without first doing some type of normalization, the
intensity level of gene i from array A, xi
A, cannot be
directly compared with the intensity level of gene i from
array B, xi
B. In this study, we sought an alternative quan-
tity or quantities that can be directly compared between
different arrays without compromising important biolog-
ical information. One obvious candidate is ri, the rank of
intensity level of gene i on the array. However, we felt that
rank is not an adequate measure because information
about relative expression level is not represented explic-
itly. Instead, we decided to use the following measures.
Let
sij = 1 if(xi - xj > 0)
0 otherwise   (1)
, where 1<= i, j <= N. Basically, sij is the sign of the inten-
sity difference of gene i and j on a single microarray and
therefore will remain unchanged under any monotonic
transformation of x. Therefore, instead of computing with
the absolute expression level of a gene, its relative level to
all the other genes on the microarray is used. For each
gene i, instead of one real valued xi, the approach uses si =
(si1, ..., sij, ..., siN), a binary vector of size N. For ease of ref-
erence, we will simply refer to this value as the SED (Signs
of Expression Difference) of gene i; and the entire matrix
(sij) the SED of the array. Given (xi), sij is simply and
uniquely defined but (sij) does not uniquely determine xi
so some information is lost by only using (sij) instead of
(xi).
Since ri = Σj = 1,...,N sij is the rank of gene i in terms of inten-
sity levels, rank information is preserved in (sij). What is
lost in the transformation from (xi) -> (sij) is just the
intensity differences between the closest ranked genes,
which in most cases are small, considering that microarray
data are generally considered "very noisy". It was our
major goal to demonstrate that (sij) has indeed captured
important components of the information from (xi).
Instead of directly using the intensity levels x, and its
derivatives such as the mean µ, the standard deviation σ
and the signal to noise ratio (S2N) between two sample
groups A and B, [(µA 
+ µB)/(σA+ σB)], we will use (sij) to
compare gene expression differences between arrays.
Since we expect measurement variations within an array
will be less than those between arrays and we take the
signs of relative expression differences to get SED, weBMC Bioinformatics 2004, 5:121 http://www.biomedcentral.com/1471-2105/5/121
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expect the SED will be less "noisy". However, the value of
any single sij may still vary between technical and biolog-
ical replicates. One would expect more sij would change
values randomly if the technical replicates was done on
arrays that were fabricated in a different run than arrays
from same run, for example. Biological variations are
expected to be even more frequent. However, we hypoth-
esize that we can perform statistical analysis on the SED,
which contains tens of thousands of sij for a single gene,
and minimize the impact of such noises.
We will also consider (spij), a natural generalization of the
SED concept. Here, spij is the probability of xi > xj. In other
words, imagining one can get a large number, n, of either
technical or biological replicates of the sample of interest,
then spij = m/n as n -> 8, where m = ΣK = 1,...,n sij
K and sK is
for replicate K. We will call (spi) = (spi1, ..., spij, ..., spiN)
the SED probabilities of gene i. Note that in calculating
both SED and SED probabilities, only intensity compari-
sons within arrays are involved and therefore forego the
normalization step.
For example, if gene i is more highly expressed in sample
A than B we would expect that more sij
A than sij
B would be
1 instead of 0 and the overall (very loosely defined) spij
A
would be larger than spij
B. Since rank can be calculated
from SED, any rank based method can be expanded to use
SED. A gene i's SED can be viewed in two different per-
spectives. On one hand, it provides information about
gene i's expression level relative to every other gene on the
array, and therefore can be used to examine gene i's
expression patterns between samples. On the other hand,
it also provides information about the expression levels of
all the other genes on the array, using the gene i as a con-
trol, in essence. Therefore, SED can be used to study ques-
tions either at the gene level or at the array level. In this
paper, we focus on solving a simpler problem at the array
level where it is not necessary to decide whether the
expression level of an individual gene is increased or
decreased between array A and B and by how much.
Rather, it is focused on whether the overall expression pat-
terns are different at all between array A and B.
Multi-class classification of tumor samples
To test whether (sij) and (spij) extracts most of the infor-
mation from (xi), we used these values in a test case of a
multi class classification problem described by Ramas-
wamy et al. and Yeang et al [19,20]. Two algorithms were
used to classify each of the 144 tumor samples into one of
14 tumor classes. One is the Naive Bayes (NB) classifier
[21] using SED probabilities. The other is the Nearest
Neighbor (NN) classifier using SED. In the NB method, to
classify a sample T, we first calculate (spij
C) for each class
C (1 <= C <= 14) using training samples, i.e. the 144 sam-
ples with T taken away (for details see methods). Then
sample T is classified according to:
score(T, C)= Σi = 1,...N Σj = 1,...,N log(pij),   (2)
where pij = spij
C if sij
T = 1
1 - spij
C otherwise
T is simply classified to the class C that has the maximum
score.
In the NN method, we compute instead, for each training
sample t,
matches(T, t) = Σi = 1,...N Σj = 1,...,N δ(sij
T, sij
t),   (3)
where δ(x, y) = 1 if x = y.
0 otherwise
Then T is classified to class C of the sample t that has the
maximum matches.
If one is to give a statistical interpretation of these scores,
one can simply view (spij) as defining a multi-binomial
probability model. In addition, one could consider each
sij as a draw from a binomial distribution with probability
pij = spij. Then, the score(T, C) is simply a logarithm of the
probability p to get all the sij exactly the same as sij
T under
the probability model C where pij = spij
C. (Since each class
defines a different probability model, score(T,C) for dif-
ference class C, in theory, should not be directly com-
pared. Instead, a P value should be calculated from the
probability model for Pr(p<exp(Score(T, C))) and used to
evaluate the closeness of sample T to each class C. For sim-
plicity, we are not considering such issues here.)
When the NB algorithm was applied to the 144 samples,
the accuracy obtained was about 63%; the NN algorithm
performed slightly better and gave an accuracy of 70%.
Feature selection
Depending on the algorithm, a better classification result
can sometimes be obtained by using a subset of genes
[22,23]. We were interested to know whether feature
selection helps to increase accuracy in our approach.
Within our framework, it is easier to treat (i,j) pairs as
selection units. We therefore filtered out (i,j) pairs where
the variance of spij across the 14 tumor classes was less
than a pre-determined value and left the rest of the algo-
rithm unchanged. We reasoned that the filtered-out part
of the matrix has less discriminating power across the
tumor spectrum and might add noise due to the small
sample sizes used. Using the NB algorithm, the best resultBMC Bioinformatics 2004, 5:121 http://www.biomedcentral.com/1471-2105/5/121
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achieved was 70% with a cutoff σ2 = 0.06, while the NN
method with σ2 = 0.05 gave 77%. Table 1 lists the accura-
cies achieved using different feature cutoffs.
"Single gene's SED" based classifier
The above procedure utilized the entire SED matrix as a
classifier. In other words, all the relations between genes
were considered in the classification. To determine
whether the inclusion of the whole matrix was actually
required to achieve the current accuracy, we investigated
the efficacy of using single gene's SED as classifiers.
In these cases, we define a classifier based on gene i and its
relative expression to every other gene. Therefore, the
scorei(T, C) = Σj = 1,...,N log(pij), where pij is as same as men-
tioned previously. Similarly, matchesi(T, t) = Σj = 1,...,N
δ(sij
T, sij
t) defines a classifier based on gene i's SED. Fig. 1
shows a display of the cumulative frequency of single gene
SED based classifiers versus accuracy for all the 16063
classifiers. In general, single gene-based classifiers per-
formed worse than the whole genome-based classifiers, as
expected. Nevertheless, most of the classifiers performed
reasonably well, compared with just using single gene
expression levels. About 80% of the single gene based
classifiers resulted in an accuracy between 40% and 60%,
while about half of the classifiers had an accuracy greater
than 50%. These results suggest that there is a lot of redun-
dant information in the SEDs and SED probabilities and
that our method should be reasonably robust. We then
investigated the number of genes that are required to
achieve the current accuracy. Fig. 2 shows the combined
results for classifiers using only a subset of genes. Our
results suggest that a subset of genes (~200) is sufficient
for predictions and that the prediction accuracy is stable
after 1000 genes.
Different classification accuracy between tumor classes
From the analyses described above, we noticed that there
was a significant difference in accuracy between different
tumor classes. For 3 classes (LY, LE, CNS) we obtained
Table 1: The relationship between accuracy (%) and the filter threshold The cross validation accuracies with Naive Bayes (NB) and 
Nearest Neighbor (NN) Methods are displayed with different filter cutoffs. The percentages of the features (gene pairs) used are listed 
as well. Since the number of features used are slightly different for different test samples, ranges are shown.
Filter Threshold No Filter 0.02 0.04 0.05 0.06 0.08
NB 63 66 68 69 70 68
NN 70 73 75 77 75 74
Features used (%) 100 41–43 12–13 4.9–5.9 1.7–2.1 0.12–0.17
Table 2: Summary of cross validation results. All 14 tumor types and their abbreviations are listed in the first column. The sample sizes 
for each tumor type and the number of successfully classified samples by the SVM algorithm (from ref. [19]), the NB (Naive Bayes) 
algorithm with cutoff σ2 = 0.06 and the NN (Nearest Neighbor) algorithm with σ2 = 0.05 are listed.
Tumor type (Abbreviation) Sample Size SVM [19] NB NN
Ovary (OV) 8 3 1 4
Lung (LU) 8 4 1 3
Bladder (BL) 8 5 7 5
Melanoma (ML) 8 5 6 6
R e n a l  ( R E ) 8556
Pancreas (PA) 8 5 6 6
Colorectal (CR) 8 6 1 3
P r o s t a t e  ( P R ) 8666
B r e a s t  ( B R ) 8734
Uterus (UT) 8 7 6 6
Mesothelioma (ME) 8 8 6 6
Lymphoma (LY) 16 16 14 16
Central Nervous System 
(CNS)
16 16 16 16
Leukemia (LE) 24 24 23 24BMC Bioinformatics 2004, 5:121 http://www.biomedcentral.com/1471-2105/5/121
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either 100% or close to 100% accuracy (see Table 2 for
detail). Since these happen to correspond to the 3 classes
with more than double the number of training samples
than the other classes, we tested whether this high accu-
racy is due to the larger sample sizes by using only 8 train-
ing samples for every tumor classes. The results were
essentially the same, indicating that sample size is not the
issue. On the other hand, there are classes where we
obtained very poor results; these often happen to be the
same classes where SVM in [19,20] performed poorly as
well (see Table 2).
We were interested in exploring the possible reasons for
misclassification. In Fig. 3, a scatterplot of the SED Match
scores (without feature selection) between 8 OV samples
and 8 CNS samples is displayed. The OV and CNS class
were selected since one is "very hard" and the other is
"very easy" to classify. Without trying to be statistically
correct, the plot does suggest that samples of the OV class
are in general "farther away" from each other, compared
with those from the CNS class. As this may be one of the
reasons that the OV class is harder to classify, algorithms
that take this kind of information into account may per-
form better than the simple ones we have presented here.
Discussion
Although we used the multi-class tumor classification
problem as our test case, our major goal was to illustrate
the feasibility of the normalization free SED approach,
and not in sample classification per se. Therefore, we chose
the algorithms NB and NN for their simplicity and not for
their performance in solving this specific problem. The
performance of a classifier depends, in this case, mainly
on the power of its algorithm, and the data representation
it used. From a machine learning perspective, one can
simply view the intensity -> SED transformation as a
change in data representation, a mapping from the gene's
attribute, intensity x, to some features SED. It was our goal
to demonstrate that the new features (SED and SED
probability), in addition to being normalization free, still
Cumulative Frequency of Single Gene SED classifiers versus  cross validation accuracy Figure 1
Cumulative Frequency of Single Gene SED classifiers 
versus cross validation accuracy. The X axis represents 
the cross validation accuracy and the Y axis represents the 
cumulative frequency of the single gene based classifiers. For 
each point (x,y) on the curve, y equals the percentage of clas-
sifiers that have an accuracy less than or equal to x. Solid 
curve – NN method with cutoff σ2 = 0.05. Dashed line – NB 
method with σ2 = 0.06.
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Evaluation of the number of genes required to achieve the  highest accuracy Figure 2
Evaluation of the number of genes required to 
achieve the highest accuracy. The X axis represents the 
number of genes used in the classifiers. The Y axis represents 
the cross validation accuracy. Solid line – NN method with 
cutoff σ2 = 0.05. Dashed line – NB method with σ2 = 0.06. X 
is in log scale. As X increases more genes are included in the 
classifier in the order they are represented in the original 
microarray (unselected for performance).
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convey the essential information in the original attribute,
the intensity x.
Since the data representation is quite different between
the intensity x (a real valued quantity) and SED (a binary
valued vector of rather large size N), it is difficult to
directly compare the two. No obvious yet non-trivial algo-
rithms work with both representations; even if there were
such an algorithm it is not clear that it would be the right
one to use for comparison as it might well be the case that
different data representation works best with different
algorithms. Here, we have limited the presentation to
some empirical results with SED representation, which are
comparable with results using several different algorithms
that are based directly on raw intensity [19,20]. Our clas-
sification results are close to those obtained with WV and
kNN methods, which are based on directly focusing on
intensity levels. Previous results using SVM were signifi-
cantly better, but we feel the differences are due more to
the power of the algorithm [24] than the way information
is coded. In fact, slightly more accurate results are
obtained with modification of algorithms that directly
manipulate intensity levels [25,26]. We do not imply that
the algorithms (NB and NN) we chose are better than
other alternatives (and we do not have empirical evidence
pointing either way). Instead, we fully expect more
sophisticated algorithms would work better with the SED
approach as well.
Certainly, SED probability is more information rich than
SED. We expect that an SED probability based analysis
would perform better than the simple binary valued SED.
In this paper, we mainly tested the SED. SED probability
is only used for a group of samples, not for single samples.
If one limits oneself to use only raw data, then for single
arrays one can only get SED. However, if some
assumptions about the patterns of gene expression levels
can be made, one can certainly get an estimation of SED
probability even for a single array. For example, as in
some nonlinear normalization algorithms, if one assumes
that the variation of expression levels are similar for genes
with similar expression levels, then one can estimate SED
probability from a probability model. Also, the magni-
tude of the intensity difference can also be used to help
such an estimation. Alternatively, as more and more
microarray data become available, one can use other sim-
ilar samples to get an estimation of a prior SED probabil-
ity, and then use a Bayesian approach to estimate the
sample's SED probability.
The obvious disadvantage of our SED based approach is
that for each gene expression level, one is not dealing with
a single real number but instead a vector of size N, where
N is in the tens of thousands. This could significantly
increase both computing time and memory requirement
(however, see methods for details) On the other hand, it
also has certain advantages: 1) It is free of normalization
noise. Since it is generally believed that biological varia-
tion is larger than technical variation and normalization
noise is just another source of technical variation, the ben-
efit here is only of a limited scope. However, it may be
important when the expression level difference one is
interested in is small. 2) In addition to being normaliza-
tion free, SED and SED probability also have the advan-
tage in being distribution free, and therefore could
perform better if the intensity levels were non-normal. 3)
SED and SED probability are easier to interpret. SED val-
ues can easily be checked against raw intensity levels
according to Eq. (1). While SED probability is one step
further away from intensity levels, one could still have an
intuitive sense of it and make comparisons between dif-
ferent experiments. It would be much harder to have a real
grasp of the absolute gene expression level, except that it
is "high" or "low" or somewhere "in between"; it is cer-
tainly harder to compare between experiments intuitively.
Scatterplot of SED Match scores of OV and CNS samples Figure 3
Scatterplot of SED Match scores of OV and CNS 
samples. The X axis represents the SED Match scores from 
eq. (3) / N2, where N = 16063, the total number of genes. 
The Y axis represents the sample id. Samples 1–8 (shown in 
red) are from class OV while 9–16 (shown in blue) are from 
class CNS. Only 8 samples from the CNS class were used for 
ease of comparison. Other samples gave similar results. For 
each sample, its Match scores / N2 against all the other 7 
samples within the class are shown. The Match scores of OV 
class are much more dispersed (to the left), compared with 
that of CNS class.
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We have only tested the SED approach on datasets that are
from the same chip format. Data from different chip for-
mats or complete different technology platforms, of
course, would be harder to compare. But they are also
challenge for normalization based method. It would
certainly be interesting to compare SED and normaliza-
tion based method under these more challenging
conditions.
If this normalization-free approach (SED) proves to retain
the essential biological information in general, its applica-
tion may be extended to meta-analysis where different
datasets could be integrated and intervalidated. The
method could also be used when the number of arrays is
a limiting factor for experiments. For example, one could
take advantage of the massive amount of public array
data, obtain prior distribution of SED probabilities from
datasets with similar conditions, and analyze new data
within a Bayesian framework. If the performance of the
nearest neighbor method in general is anywhere close to
what we demonstrated in the multi tumor classifications
here (as is clear from Eq. (3) and Fig. 3, the nearest
neighbor method, without feature selection at least,
allows direct sample vs. sample comparison. Note also
that the samples in the multi tumor problems are from
different biological specimens, therefore, large between-
sample-variation is expected), it might be used as a micro-
array database query method, i.e., to find similar microar-
ray results in the database that are "similar" to one's own,
independent of array annotations.
It might also be worth noting that the SED approach
could easily be applied to other kinds of comparative data
analysis for samples with very large numbers of "noisy"
attributes. The SED approach may also perform better
when between-sample-variation is large, especially if such
variation contains some rather uninteresting technical
measurement errors that would not affect within-sample-
variations.
Conclusions
We have proposed a new approach to analyze microarray
data and tested the method on a set of publicly available
datasets. The results were comparable to those obtained
with some widely used normalization based algorithms.
We hope that we have demonstrated that this normaliza-
tion free method is feasible and promising. We think the
SED based, normalization free approach could be used to
complement the more popular normalization based
approaches in microarray data analysis.
Methods
Microarray data for multiple tumor samples were down-
loaded from http://www.broad.mit.edu/cancer/software/
genepattern/datasets/. Naive Bayes and Nearest Neigh-
bour Classifiers were implemented in the Java
programming language. Ad hoc analysis was done with
perl scripts. Graphics were generated using the R comput-
ing environment.
Naive Bayes method
Because of the uneven and relatively small sample sizes
for each tumor class (mostly 8 but up to 24), extra care
was taken in computing spij. Assuming a prior probability
of 0.5, spij was estimated by Bayesian posterior probability
(m+1)/(n+2) where n is the total number of samples in
the class and m is the total number of samples where xi >
xj. For classes that were over-represented (sample size > 8),
the threshold of spij was set to [0.125, 0.875], since the NB
method is sensitive to the extreme values of sp, and sam-
ples can be over-predicated without thresholds.
In addition, several alternatives were tested to demon-
strate that our results were reasonably robust and not sen-
sitive to the particular choices we made:
1) To examine the influence of the sample size, in a sepa-
rate analysis the sample size of ME, LE, CNS class was arti-
ficially reduced to 8, i.e. only the first 8 samples were used
to calculate spij  with no significant change of results
observed;
2) Since spij depends on the sample size n for each tumor
class, we have applied a "sample replacement" strategy in
addition to the usual "take-one-sample-out" approach for
cross-validation, i.e. when one sample is taken out as the
test sample, another sample from the same class is dupli-
cated to take its place to keep the sample size constant.
Essentially the same results were obtained. Results
reported are from the sample replacement runs.
In Feature Filtering, the variance of spij between all 14
classes was calculated as:
σ2 = (ΣC = 1,...,14,spij
C * spij
C)/14 - ((ΣC = 1,...,14 spij
C)/14)2
(4)
with the test sample taken out, and used as the criterion
for feature exclusion.
Nearest neighbor method
Feature filter was done as in the Naive Bayes Method.
Software implementation and availability
The analysis was done on a computer (Pentium M 1.5
GHz) operating under Microsoft XP. Both Naïve Bayes
and Nearest Neighbor Classifiers are implemented in Java.
Since SED can be easily calculated from the raw intensities
only the later are kept in memory and SED are computedBMC Bioinformatics 2004, 5:121 http://www.biomedcentral.com/1471-2105/5/121
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from the intensities on an as-needed bases. Memory
needed to analysis the 144 samples is less than 64 MB.
The most computationally intensive algorithm that we
tried is the Nearest Neighbor method without any feature
selections and it takes about 10 sec to calculate SED score
for one pair of tumor samples with about 16000 genes.
A Java program named SED (including source code) to
perform nearest neighbor analysis of microarray samples
is freely available by contacting author at hw14@colum-
bia.edu.
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